CATHERINE SLAUGH: Open Payments
NPI 1871251595 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 36 payments from 15 companies in 2025. Trend: 2023 $779 · 2024 $529 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Amgen Inc. | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Tactile Systems Technology Inc | 3 | $55 |
| Lilly USA, LLC | 2 | $54 |
| SCPHARMACEUTICALS INC. | 1 | $34 |
| Medtronic, Inc. | 1 | $27 |
Products named: LEQVIO, VERQUVO, REPATHA, Kerendia, FARXIGA, Flexitouch Plus, CAMZYOS, ELIQUIS.
Industry payments across DE — which companies pay providers there.
